Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids - The step 3 dilemma

Medicine and Dentistry

• Beta 2 Adrenergic Receptor Stimulating Agent 100%
• Asthma 100%
• Leukotriene Receptor Blocking Agent 81%
• Agonist-Antagonist 36%
• Anti-Inflammatory Drug 27%
• Lung 27%
• Add on Therapy 18%
• Allergic Rhinitis 18%
• Airway Smooth Muscle 9%
• Quality of Life 9%
• Allergen 9%
• Respiratory Tract Inflammation 9%
• Pathophysiology 9%
• Bronchodilatation 9%
• Bronchoconstriction 9%
• Bronchodilating Agent 9%
• Airway Obstruction 9%
• Severe Asthma 9%
• Serositis 9%

Immunology and Microbiology

• Agonist 100%
• Asthma 100%
• Isoetarine 100%
• Leukotriene Antagonist 81%
• Airway 27%
• Allergic Rhinitis 18%
• Allergen 9%
• Severe Asthma 9%
• Pathophysiology of Asthma 9%
• Bronchodilatation 9%
• Smooth Muscle 9%
• Bronchodilator 9%
• Airflow 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Beta 2 Adrenergic Receptor Stimulating Agent 100%
• Asthma 100%
• Leukotriene Receptor Blocking Agent 81%
• Agonist-Antagonist 36%
• Anti-Inflammatory Drug 27%
• Add on Therapy 18%
• Allergic Rhinitis 18%
• Pathophysiology 9%
• Syndrome 9%
• Bronchodilating Agent 9%
• Bronchoconstriction 9%
• Allergen 9%
• Respiratory Tract Inflammation 9%
• Airway Obstruction 9%
• Inflammation 9%